Elevance Health, Inc. (LON:0HG8)
London
· Delayed Price · Currency is GBP · Price in USD | Market Cap | 72.50B |
| Revenue (ttm) | 141.23B |
| Net Income (ttm) | 4.78B |
| Shares Out | n/a |
| EPS (ttm) | 20.51 |
| PE Ratio | 15.18 |
| Forward PE | n/a |
| Dividend | 5.13 (1.20%) |
| Ex-Dividend Date | Mar 10, 2025 |
| Volume | 262 |
| Average Volume | 1,233 |
| Open | 390.00 |
| Previous Close | 438.33 |
| Day's Range | 385.00 - 440.12 |
| 52-Week Range | 385.00 - 516.42 |
| Beta | 0.78 |
| RSI | 48.42 |
| Earnings Date | Apr 16, 2025 |
About Elevance Health
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. It operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. The company offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, a... [Read more]
Financial Performance
In 2024, Elevance Health's revenue was $176.81 billion, an increase of 3.19% compared to the previous year's $171.34 billion. Earnings were $5.98 billion, a decrease of -0.12%.
Financial numbers in USD Financial StatementsNews
Which Stocks Stayed Green as the Market Plummeted?
Only a handful of S&P 500 stocks managed to generate gains during the market's historic four-day plunge.
GreensKeeper Q1 2025 Portfolio Update
Berkshire Hathaway led Q1 with a 17.5% return, driven by strong operating earnings and potential for significant acquisitions with over $300 billion in cash. Vertex Pharmaceuticals gained 20.4%, fuele...
These 20 stocks have risen during Trump's trade tirade. Analysts see up to 30% additional upside.
The stock market doesn't react well to uncertainty. And the daily headlines about new tariffs being placed on U.S. imports and possible negotiations with trading partners to do away with tariffs have ...
Mizuho's Jared Holz: Here's why healthcare stocks are under pressure
Jared Holz, Mizuho Securities America healthcare sector strategist, joins CNBC's 'Power Lunch' to discuss whether the healthcare sector is actually a safe haven during the market turmoil, why healthca...
US Health Insurance Stocks Rally After $25 Billion Federal Boost To Medicare Payments
Health insurance stocks soared Tuesday morning on the first full day of trading after the U.S. government announced a more than 5% average increase in government reimbursement rates for 2026 Medicare ...
Humana and Other Health Insurance Stocks Surge on Higher-Than-Expected Medicare Payments
Shares of health insurance operators surged Tuesday after the government said it would pay a higher rate to Medicare insurers than previously estimated.
Health insurance stocks rise on 'best case scenario' Medicare payment rates
Shares of U.S. health insurers jumped on Tuesday after a bigger-than-expected increase in the government's reimbursement rates for Medicare Advantage plans in 2026, bringing some relief to a sector bu...
Potatoes, discount chains and drugmakers offer havens in stock-market bloodbath
Potato maker Lamb Weston Holdings Inc., telecom giant Verizon Communications Inc., drug maker AbbVie Inc. and retailer TJX Cos. all bucked a sharp market selloff Thursday, as Wall Street turned to sto...
Elevance Health to Hold Conference Call and Webcast to Discuss First Quarter 2025 Results on April 22, 2025
INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health (NYSE: ELV) will release first quarter 2025 financial results on April 22, 2025, at 6:00 a.m. Eastern Daylight Time (“EDT”). Management will review these...
Here's How Much $100 Invested In Elevance Health 15 Years Ago Would Be Worth Today
Elevance Health (NYSE: ELV) has outperformed the market over the past 15 years by 2.43% on an annualized basis producing an average annual return of 13.42%. Currently, Elevance Health has a market ca...
44th Move: Anthem review – veers admirably from the beaten path
(Black Acre) Pianist and producer Alfa Mist’s latest project, with drummer Richard Spaven, showcases two musicians at the top of their game In the London jazz scene of the past decade, pianist and pro...
Elevance Health: Add A Little Bit Of Health To Your Defensive Portfolio
Regulatory changes under Trump's administration and AI integration are key factors influencing Elevance Health's future growth. Read why ELV stock remains a Buy.
Here's How Much You Would Have Made Owning Elevance Health Stock In The Last 15 Years
Elevance Health (NYSE: ELV) has outperformed the market over the past 15 years by 2.24% on an annualized basis producing an average annual return of 13.22%. Currently, Elevance Health has a market ca...
Elevance Health gains after CFO comments at investor event
Top Companies for Social Responsibility
Intel heads the list, followed by Elevance Health and Accenture
Maximizing Returns: 3 Compelling Reasons To Invest In Elevance Health Now
Due to heightened political uncertainty, health insurer and pharmacy benefit manager, Elevance Health, continues to be shunned by the market. While I focused on the challenges and risks in my last art...
U.S. Managed Care Q4 2024 Earnings Recap: Medical Costs Continue To Mount
US managed care insurers' fourth quarter 2024 earnings season was characterized by generally higher medical costs amid ongoing changes to federally subsidized healthcare plans that, in some cases, res...
Elevance Health Inc (ELV) Stock Price Up 3.38% on Feb 25
Elevance Health Inc (ELV) Stock Price Up 3.38% on Feb 25
Is the Market Bullish or Bearish on Elevance Health?
Elevance Health's (NYSE: ELV) short percent of float has fallen 3.97% since its last report. The company recently reported that it has 2.81 million shares sold short , which is 1.21% of all regular s...
Defensive, Sector-Based Dividend Growth: 6 Opportunities And One Special Highlight (Part 1)
Dividend growth investing can offer high-quality stocks, with small dividends growing in the 10-15% range, providing impressive investment opportunities. Diversified, large-cap companies with strong r...
Stocks to watch for: Elevance Health, Accenture PLC and more
Chad Morganlander, senior portfolio manager at Washington Crossing Advisors, shares his outlook on promising stocks in the health and tech sectors.
Elevance Health Bolsters Employer Insurance Business
Elevance Health says its acquisition of Verily's Granular Insurance Company is designed to bolster its offerings to self-funded employer clients. Financial terms of the deal aren't being disclosed, an...
Alphabet’s Verily in pact with Elevance Health to offload insurance business
Alphabet's Verily Sells Granular Insurance To Elevance Health Amid Healthcare Strategy Refocus
Verily , Alphabet Inc. ‘s (NASDAQ: GOOGL) (NASDAQ: GOOG) health technology subsidiary, announced Thursday it will sell its stop-loss insurance business, Granular Insurance Company , to Elevance Heal...
Alphabet's Verily to sell Granular insurance business to Elevance Health
Alphabet's Verily is selling its subsidiary, Granular Insurance Company, to Elevance Health.